Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD7 CAR-T in Relapsed/Refractory Acute Leukemia
NCT06585345Phase 2Recruiting
- Sponsor
- General Hospital of Western Theater Command of PLA
- Start
- Feb 2024
- Primary completion
- Dec 2027
- Modality
- Autologous CAR-T
- Countries
- 1
01
Overview
A Phase 2 trial of CD7 CAR-T cells injection in acute leukemia, sponsored by General Hospital of Western Theater Command of PLA. Started Feb 2024; status: recruiting.
02
Drugs
CD7 CAR-T cells injection
03
Conditions
acute leukemia
Beyond the preview
Go deeper on NCT06585345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06585345.